Sale of the low-pressure coolant ODIN enables NANO Nuclear to sharpen focus on its portfolio of gas-cooled technologies - KRONOS MMR, LOKI MMR, and ZEUS - and maximize developmental and regulatory efficiencies and long-term commercial advancement. New York, New York--(Newsfile Corp. - September 17, 2025) - NANO Nuclear Energy Inc. (NASDAQ: NNE) ("Nano Nuclear" or the "Company"), a leading advanced nuclear energy and technology company, today announced the signing of a letter of intent for the proposed sale of its ODIN™ low-pressure coolant microreactor design and all associated intellectual property to Cambridge Atom Works, a United Kingdom based advanced reactor …

- Efficacy and safety results from successful NAVIGATE Phase 2b trial of CD388 for prevention of influenza illness featured in late-breaking presentation - Preclinical data demonstrating potential efficacy of CD388 to prevent H5N1 infection featured in oral presentation SAN DIEGO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced two presentations during the International Society for Respiratory Viruses (ISRV) 8th AntiViral Group (AVG) Meeting and 3rd International Meeting on Respiratory Pathogens (IMRP).

SAN DIEGO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a Technology Company in the Defense, National Security and Global Markets and the National Chung-Shan Institute of Science and Technology (NCSIST) have partnered to introduce the Mighty Hornet IV Attack UAV, a revolutionary transformation of the MQM-178 target drone.

BOCA RATON, FL, Sept. 17, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced the acquisition of 62,745 SOL.

PHILADELPHIA, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) today confirmed that its Global Industry Classification Standard (GICS) designation, as determined by MSCI Inc. and S&P Dow Jones Indices, has been reclassified to 20101010 – Aerospace & Defense, effective September 30, 2025.

THORNTON, Colo. and NEW YORK, Sept.

EL SEGUNDO, Calif.--(BUSINESS WIRE)--Teledyne Controls, a business unit of Teledyne Technologies Incorporated (NYSE:TDY), and a leading provider of avionics and aircraft data management solutions, is pleased to announce that the Federal Aviation Administration (FAA) has granted Supplemental Type Certificate (STC) approval for the installation of their enhanced Airborne Data Loader, eADL XS™, on the Airbus A320 family of aircraft, including the A318, A319, A320, and A321 models. Teledyne's eADL.

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--PennyMac Mortgage Investment Trust (NYSE: PMT) announced today that its Board of Trustees declared a cash dividend of $0.40 per common share of beneficial interest for the third quarter of 2025. This dividend will be paid on October 24, 2025, to common shareholders of record as of October 10, 2025. About PennyMac Mortgage Investment Trust PennyMac Mortgage Investment Trust is a mortgage real estate investment trust (REIT) that invests primarily in resi.

JACKSONVILLE, Fla.--(BUSINESS WIRE)--FIS® (NYSE: FIS), a global leader in financial technology, today announced a major leap forward in empowering banks to modernize faster and more effectively than ever before. Rather than limiting transformation to core systems alone, FIS' new Bank Modernization Framework sets its sights on modernizing the full banking ecosystem. This approach empowers financial institutions to tailor their modernization journeys to their current needs, allowing them to begin.

NEW YORK, NY / ACCESS Newswire / September 17, 2025 / Every once in a while, an industry has its thunderbolt moment. Recycling just had its.

DARMSTADT, Germany--(BUSINESS WIRE)--Not intended for UK-, US- or Canada-based media Merck, a leading science and technology company, today announced the presentation of over 30 abstracts from its multiple sclerosis (MS) portfolio. New four-year data from two large Phase 4 studies highlight the long-term efficacy, favorable disability outcomes and durable impact of MAVENCLAD® (cladribine tablets) in people living with relapsing multiple sclerosis (RMS). These findings are to be presented at the.

RICHMOND, Va.--(BUSINESS WIRE)--NewMarket Corporation (NYSE: NEU) today announced its entry into a definitive purchase agreement to acquire Mars TopCo, LLC, the ultimate parent company of Calca Solutions, LLC (Calca). Calca is currently a portfolio company of AE Industrial Partners, LP. Based in Lake Charles, Louisiana, Calca is the leading U.S. manufacturer of UltraPure and high purity hydrazine – mission critical chemicals used in a wide range of applications. Most notably, these products are.

NEW YORK & LONDON & MUMBAI, India--(BUSINESS WIRE)---- $WNS #Acquisition--WNS updates progress on acquisition by Capgemini.

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Medincell (Paris:MEDCL): Data from the completed phase 3 SOLARIS trial to be presented at the 2025 Psych Congress Annual Meeting, taking place from September 17 – 21, 2025, in San Diego, California Teva will host a conference call for analysts and investors on Monday, September 22, 2025, at 11:00 am ET to discuss these data To access a live webcast of the presentation, visit Teva's Investor Relations website at https://ir.tevapharm.com/Even.

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it has renewed its sponsorship agreement with professional golfer Neal Shipley and signed new sponsorship agreements with Bud Cauley, Ryan Fox and Darren Clarke. These endorsements reflect Claritev's commitment to supporting athletes who exemplify resilience, determinatio.

The biggest names in tech are racing to make advertising easier, especially for small businesses and consumer goods companies.

FORT LEE, N.J.--(BUSINESS WIRE)--Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing novel adult retinal pigment epithelial stem cell (RPESC) therapies for dry age-related macular degeneration (dry AMD), today announced the publication of Phase 1/2a clinical trial results in a paper titled "Safety and Tolerability of RPE Stem Cell-derived RPE Transplantation in Patients with Dry Age-related Macular Degeneration: Low Dose Clinical Outcomes" in the journal Cell Stem C.

BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced positive initial results from the Phase 1a trial of STAR-0310, a YTE half-life extended monoclonal antibody antagonist of OX40, in healthy subjects. STAR-0310 demonstrated a best-in-class half-life of up to 68 days, consistent with administration every six months, durable cytokine inhibition, and was we.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced the publication of two peer-reviewed research papers describing innovative bioproduction strategies for creating therapeutic compounds. While Enveric's lead candidate EB-003 is manufactured using established synthetic chemistry methods common to the.

IRVINE, Calif.--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the launch of a new brand, “Hada no Aozora Clinic”, scheduled to open in Tokyo on October 1, 2025. This clinic will adopt a hybrid dermatology model that integrates insurance-covered general dermatology and private-pay aesthetic treatments, advancing SBC's multi.